Sustainable Anaesthesia Practices in EUROPE - a Prospective International Cohort Study

NCT ID: NCT07252973

Last Updated: 2025-11-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

2000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2026-03-01

Study Completion Date

2027-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In response to the climate crises, Societies of Anaesthesiology around the globe call for action to reduce the carbon footprint of daily clinical work. They recommend the use of regional and total intravenous anaesthesia, and for inhalational anaesthesia cases, the use of sevoflurane with low fresh gas flow (FGF \< 0.5 lpm) settings. Surprisingly, the type of anaesthesia and ventilation settings commonly used remain largely unknown. This pragmatic observational cross-sectional assessment at all anaesthesia workstations in participating European hospitals in daily routine aims to evaluate anaesthesia practices in the paediatric and adult patient population.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anaesthesia Conduction Paediatric and Adult Patients Carbon Footprint in Anesthetic

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Anaesthesia technique

Observation of type of anaesthesia used in Europe

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients receiving any form of anaesthesia care-whether general or regional anaesthesia, monitored sedation, or monitoring only-from an anaesthetist at an anaesthesia workstation in participating European hospitals during the selected data-collection recruitment period

Exclusion Criteria

* Patients (or legal guardians) who decline consent and patients for whom valid informed consent cannot be obtained due to language barriers or other factors preventing adequate information and understanding.
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

European Society of Anaesthesiology

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CTN_SUSTAIN-EUROPE

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Inhaled Sevoflurane for ARDS Prevention
NCT05849779 RECRUITING PHASE3
SEvoflurane for Sedation in ARds
NCT04235608 COMPLETED PHASE3
Inhaled Sedation in Critically Ill Patients
NCT07000526 RECRUITING PHASE4